Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
about
Autophagy in cardiovascular biologyShedding new light on neurodegenerative diseases through the mammalian target of rapamycinLeptin augments coronary vasoconstriction and smooth muscle proliferation via a Rho-kinase-dependent pathwayMammalian target of rapamycin (mTOR) induces proliferation and de-differentiation responses to three coordinate pathophysiologic stimuli (mechanical strain, hypoxia, and extracellular matrix remodeling) in rat bladder smooth muscle.Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectinUnique remodeling processes after vascular injury in intracranial arteries: analysis using a novel mouse model.Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.The effect of ferulic acid ethyl ester on leptin-induced proliferation and migration of aortic smooth muscle cells.Mammalian target of rapamycin signaling in diabetic cardiovascular diseaseSulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese micePerivascular fat, AMP-activated protein kinase and vascular diseases.Vascular smooth muscle cell proliferation in restenosis.Adipokines and the cardiovascular system: mechanisms mediating health and disease.Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells.Egr-1 mediates leptin-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells.Leptin Induces Sca-1+ Progenitor Cell Migration Enhancing Neointimal Lesions in Vessel-Injury Mouse Models.Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells.
P2860
Q26866165-9E22F503-8B27-4554-8FD9-2F53B4F93896Q27015640-E24FCE53-09BC-4D38-82B7-35169D43D0C7Q28395130-31F773F8-62F8-4110-A67D-ADDC8420435AQ33556349-C324D95F-910C-47F7-822F-8020C456B865Q34118648-EAB5983F-7AFC-4656-A6FE-5C8E27F73160Q34661004-B0E55778-6B54-4B16-99A2-4748BD9C5AC7Q35589548-A9DE9455-0C30-456D-B2F3-33958DA48EC1Q36022213-9944C311-45A1-431A-AD02-F403002A9F12Q36100715-778D6AF4-4539-4BDC-9EAA-56991540DC51Q36923666-15B59CB0-93AE-4AEF-9081-19C61C868DBCQ37671282-F85AD09C-EC68-4F0B-BE90-111079361DEBQ37843083-5D067467-6592-467A-8332-31E8548B6388Q38014474-0C633E78-AAFD-4EA8-95E4-FADA4CE41AABQ39605054-A18B5BE9-1809-4A69-A46B-A20679325DA8Q47688121-09E6B318-AECE-47C4-B191-4AB9F2DADB31Q47764682-01E21E00-3FA2-4D9E-9213-E8DCDDBE3893Q53228725-E5828756-B8E5-4375-89CF-AC2F5EE5BAA3
P2860
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
@en
type
label
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
@en
prefLabel
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
@en
P2093
P2860
P356
P1476
Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.
@en
P2093
Andrew R Marks
Hana Totary-Jain
Hayes Dansky
Steven O Marx
Thomas B Nguyen
P2860
P304
19006-19011
P356
10.1073/PNAS.0809743105
P407
P577
2008-11-19T00:00:00Z